Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000950170-23-052408)

Filing Details

Accession Number:: 0000950170-23-052408
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-10-06 16:26:25
Reporting Period:: 2023-10-04

Accepted Time:: 2023-10-06 16:26:25
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1840229	Mink Therapeutics Inc.	INKT	Biological Products, (No Disgnostic Substances) (2836)	DE

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1098972	Agenus Inc	3 Forbes Road Lexington MA 02421		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-10-04	15,001	$1.09	21,749,888	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Open market purchases reported on this line occurred at a weighted average price of $1.0919 (range of $1.02 to $1.10).
Agenus Inc. undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price.